The A-T Children’s Project is funding two new research grants that may provide insights regarding brain function in A-T. The Florida-based Wobbly Feet Foundation has agreed to co-fund part of each grant in an on-going partnership to accelerate A-T research.

Research for the first grant, entitled “Linking neurodegeneration to protein turnover in ataxia-telangiectasia,” will be led by Shyamal Desai, PhD from the Louisiana State University Health Sciences Center School of Medicine. Dr. Desai will examine whether or not defects in protein degradation or breakdown contribute to brain cell death in A-T.

With the second grant, entitled “PCD mice as an animal model of ataxia in A-T,” Kamran Khodakhah, PhD from the Albert Einstein College of Medicine will explore the consequences of Purkinje cell loss on the function of the cerebellum, the area of the brain affected in A-T.

The more scientists can learn about the underlying defects in ATM deficient brain cells, and how brain cell interactions are impacted by those defects, the better chance they have of discovering therapeutic targets for this disorder.

Contact Us

Related News

Feb 15 @ 12:28 pm

Race with the A-T CureTeam at Disney!

Announcing the CureTeam's Walt Disney World race schedule!

more
Feb 15 @ 12:28 pm

Disappointing Results from Quince’s Clinical Trial of eDSP in A-T

Quince Therapeutics reports topline results from their Phase 3 “NEAT” trial in A-T.

more
Feb 15 @ 12:28 pm

Press Release about Intrabio’s A-T Trial Results

IntraBio announces positive trial results of Levacetylleucine for the treatment of ataxia-telangiectasia.

more
Feb 15 @ 12:28 pm

Encouraging News from an A-T Clinical Trial

IntraBio announced positive results from its pivotal Phase III clinical trial of a drug for children and adults

more